Journal of Cancer Therapy
Vol.7 No.1(2016), Paper ID 63102, 5
pages
DOI:10.4236/jct.2016.71006
Correlation of an ex Vivo Model with Clinical Application of an Epigenetic Modifier, Inhibiting Tumor Growth and Metastasis, in Resistant Cholangiocarcinoma—A Case Study
M. A. Nezami, Aron Gould Simon, Geoffrey Bartholomeusz
Pacific Medical Center of Hope Inc., Fresno, CA, USA
Valley Metabolic Imaging (VMI), Fresno, CA, USA
Si RNA Department, Experimental Therapeutics, MD Anderson Cancer Center, Houston, TX, USA
Copyright © 2016 M. A. Nezami, Aron Gould Simon, Geoffrey Bartholomeusz et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Nezami, M. , Simon, A. and Bartholomeusz, G. (2016) Correlation of an
ex Vivo Model with Clinical Application of an Epigenetic Modifier, Inhibiting Tumor Growth and Metastasis, in Resistant Cholangiocarcinoma—A Case Study.
Journal of Cancer Therapy,
7, 50-54. doi:
10.4236/jct.2016.71006.